Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk

Aruna Das Pradhan, Robert J. Glynn, Jean-Charles Fruchart, Jean G. MacFadyen, Elaine S. Zaharris, Brendan M. Everett, Stuart E. Campbell, Ryu Oshima, Pierre Amarenco, Dirk J. Blom, Eliot A. Brinton, Robert H. Eckel, Marshall B. Elam, João S. Felicio, Henry N. Ginsberg, Assen Goudev, Shun Ishibashi, Jacob Joseph, Tatsuhiko Kodama, Wolfgang Koenig, Lawrence A. Leiter, Alberto J. Lorenzatti, Boris Mankovsky, Nikolaus Marx, Børge G. Nordestgaard, Dénes Páll, Kausik K. Ray, Raul D. Santos, Handrean Soran, Andrey Susekov, Michal Tendera, Koutaro Yokote, Nina P. Paynter, Julie E. Buring, Peter Libby, Paul M Ridker

Open source

DOI: 10.1056/nejmoa2210645
Published: 2022-11-24
Container: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa2210645,
  title = {Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk},
  author = {Aruna Das Pradhan and Robert J. Glynn and Jean-Charles Fruchart and Jean G. MacFadyen and Elaine S. Zaharris and Brendan M. Everett and Stuart E. Campbell and Ryu Oshima and Pierre Amarenco and Dirk J. Blom and Eliot A. Brinton and Robert H. Eckel and Marshall B. Elam and João S. Felicio and Henry N. Ginsberg and Assen Goudev and Shun Ishibashi and Jacob Joseph and Tatsuhiko Kodama and Wolfgang Koenig and Lawrence A. Leiter and Alberto J. Lorenzatti and Boris Mankovsky and Nikolaus Marx and Børge G. Nordestgaard and Dénes Páll and Kausik K. Ray and Raul D. Santos and Handrean Soran and Andrey Susekov and Michal Tendera and Koutaro Yokote and Nina P. Paynter and Julie E. Buring and Peter Libby and Paul M Ridker},
  year = {2022},
  journal = {New England Journal of Medicine},
  doi = {10.1056/nejmoa2210645},
  url = {https://doi.org/10.1056/nejmoa2210645}
}

RIS

TY  - JOUR
TI  - Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk
AU  - Aruna Das Pradhan
AU  - Robert J. Glynn
AU  - Jean-Charles Fruchart
AU  - Jean G. MacFadyen
AU  - Elaine S. Zaharris
AU  - Brendan M. Everett
AU  - Stuart E. Campbell
AU  - Ryu Oshima
AU  - Pierre Amarenco
AU  - Dirk J. Blom
AU  - Eliot A. Brinton
AU  - Robert H. Eckel
AU  - Marshall B. Elam
AU  - João S. Felicio
AU  - Henry N. Ginsberg
AU  - Assen Goudev
AU  - Shun Ishibashi
AU  - Jacob Joseph
AU  - Tatsuhiko Kodama
AU  - Wolfgang Koenig
AU  - Lawrence A. Leiter
AU  - Alberto J. Lorenzatti
AU  - Boris Mankovsky
AU  - Nikolaus Marx
AU  - Børge G. Nordestgaard
AU  - Dénes Páll
AU  - Kausik K. Ray
AU  - Raul D. Santos
AU  - Handrean Soran
AU  - Andrey Susekov
AU  - Michal Tendera
AU  - Koutaro Yokote
AU  - Nina P. Paynter
AU  - Julie E. Buring
AU  - Peter Libby
AU  - Paul M Ridker
PY  - 2022
JO  - New England Journal of Medicine
DO  - 10.1056/nejmoa2210645
UR  - https://doi.org/10.1056/nejmoa2210645
ER  -

APA

Pradhan, A. D., Glynn, R. J., Fruchart, J., MacFadyen, J. G., Zaharris, E. S., Everett, B. M., Campbell, S. E., Oshima, R., Amarenco, P., Blom, D. J., Brinton, E. A., Eckel, R. H., Elam, M. B., Felicio, J. S., Ginsberg, H. N., Goudev, A., Ishibashi, S., Joseph, J., Kodama, T., Koenig, W., Leiter, L. A., Lorenzatti, A. J., Mankovsky, B., Marx, N., Nordestgaard, B. G., Páll, D., Ray, K. K., Santos, R. D., Soran, H., Susekov, A., Tendera, M., Yokote, K., Paynter, N. P., Buring, J. E., Libby, P., & Ridker, P. M. (2022). Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2210645

Source records

crossref · retrieved 2026-11-05T10:38:01.928Z